Progressive Multifocal Leukoencephalopathy Presenting as Primary CNS Malignancy in an Immunocompetent Patient

Rachel D Truong1, Vamshi K Vadlapatla2, Nicholas G Avgeropoulos2

  • 1Department of Internal Medicine, Orlando Regional Medical Center, Orlando, USA.

Cureus
|October 25, 2023
PubMed

Insights

Progressive multifocal leukoencephalopathy (PML), a John Cunningham virus (JCV) infection, mimicked central nervous system lymphoma in an immunocompromised patient. This case highlights PML

Area of Science:

  • Neurology
  • Infectious Diseases
  • Oncology

Background:

  • Progressive multifocal leukoencephalopathy (PML) is a rare, opportunistic infection caused by the John Cunningham virus (JCV).
  • PML typically affects immunocompromised individuals, presenting with diverse neurological deficits.
  • Differential diagnosis of PML can be challenging, often overlapping with primary central nervous system (CNS) tumors.

Observation:

  • A 74-year-old male presented with progressive memory loss, confusion, and aphasia over six weeks.
  • Brain MRI and spectroscopy suggested primary CNS lymphoma or diffuse glioma.
  • Stereotactic brain biopsy revealed findings suggestive of viral infection, confirmed as PML by JCV DNA in-situ hybridization (ISH).

Findings:

  • The patient was diagnosed with PML, initially misdiagnosed as CNS lymphoma.
  • JCV DNA in-situ hybridization (ISH) was crucial for confirming the PML diagnosis.
  • The patient's neurological condition improved spontaneously without specific antiviral treatment.

Implications:

  • This case represents the first reported instance of primary PML presenting as CNS lymphoma in contemporary medical literature.
  • Highlights the importance of considering infectious etiologies, including PML, in the differential diagnosis of CNS lesions.
  • Emphasizes the diagnostic utility of JCV DNA ISH in complex neurological cases.